Information relating to the total number of voting rights and the number of shares making up the share capital
Paris, June 2, 2023
VISIOMED GROUP (FR0013481835 – ALVMG) publishes information relating to the total number of voting rights and the number of shares making up its share capital, in accordance with the provisions of article 223-16 of the General Regulations of the Autorité des marchés financiers .
Date | Number of actions | Number of voting rights | |
May 31, 2023 | 294 356 419 | Theoretical | 294 401 826 |
Exercisable | 294 214 035 | ||
1
The total number of exercisable voting rights is calculated on the basis of all the theoretical voting rights minus the shares deprived of voting rights.
About Visiomed Group
Created in 2007, Visiomed Group relies on a long experience in the health sector to invest in innovative health technologies and services in France and abroad.
The Group currently has two assets and holdings:
-
Smart Salem, the first digital medical analysis center accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, 100% owned by Visiomed Group.
The Smart Salem offer is based on know-how in medical analysis, radiology and data analysis and processing to detect nearly 35 diseases in 7 minutes in a patient (in particular HIV, hepatitis and tuberculosis) by offering reliable results. , readability and exceptional patient experience enabled by advanced artificial intelligence and virtual reality technologies.
Smart Salem’s “Medical Fitness Assessment” offer resulting from this know-how thus makes it possible to obtain a residence or work visa in the space of 30 minutes.
Smart Salem is a technological platform offering many growth opportunities, as shown by the opening of the second center in Dubai in September 2022 and the authorization received for the opening of a third center in the first quarter of 2023.
-
Bewellthy, created in 2022, a leading player in connected health and teleconsultation solutions and 49.88% owned by Visiomed Group.
Bewellthy offers an enriched technological universe combining medical devices, software and “health and well-being concierge” services to meet all the needs and use cases of telehealth.
Bewellthy’s flagship product, VisioCheck, is the first telemedicine station weighing less than 300g for healthcare professionals, available in a case, station or modular health space.
Bewellthy is now deploying its solutions and services in France and abroad, particularly in Italy and the USA.
Based in Paris, Visiomed Group is listed on Euronext Growth (ALVMG). More information on www.visiomed-group.com
CONTACTS
Jérôme FABREGUETTES LEIB | Fatou-Kine N’DIAYE |
Investor Relations | Financial Press Relations |
Phone: 01 53 67 36 78 | Phone: 01 53 67 36 34 |
© Visiomed Group SA 2023. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
m2yckZxpapiYnHJtk8hqaGOVbm6UxGLGbmWVyGKcapqXbXBmm5xkb5eeZnFhl2po
– To check this key:
https://www.security-master-key.com.
Regulated information:
Total number of voting rights and capital:
– Information relating to the total number of voting rights and shares making up the capital
Full and original press release in PDF format:
https://www.actusnews.com/news/80252-visiomed_ddv_v202300602.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com